abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página não está disponível em Português e está sendo exibida em English

Artigo

19 Out 2021

Author:
Phil Helsel, NBC News (USA)

USA: States vow to fight Purdue Pharma bankruptcy plan that shields company owners from opioid lawsuits

"States vow to fight Purdue Pharma bankruptcy plan that shields Sacklers from opioid lawsuits", 1 Sept 2021

At least two states and Washington, D.C., are preparing appeals over a bankruptcy plan for the maker of OxyContin that would shield Sackler family owners from future lawsuits.

Purdue Pharma, which makes OxyContin, was dissolved … in the settlement that will require members of the Sackler family to spend billions to address the deadly opioid epidemic.

The attorneys general for Connecticut, Washington state and Washington, D.C., said it requires the Sackler family to pay $4.3 billion to states and municipalities over nine years — while they say the Sackler family made at least $11 billion in profits as the opioid epidemic raged.

The plan, which Purdue Pharma values at more than $10 billion, dissolves the drugmaker and shifts assets to a new company not controlled by Sackler family members. It also sets up a compensation fund that will pay some victims of drugs an expected $3,500 to $48,000 each.

The drugmaker itself will be reorganized into a new charity-oriented company with a board appointed by public officials and will funnel its profits into government-led efforts to prevent and treat addiction.

The agreement also includes legal releases shielding Sackler family members from future opioid litigation, a provision that some states opposed…

Purdue Pharma filed for bankruptcy in 2019 amid an onslaught of litigation. Roughly 3,000 lawsuits nationwide sought to pin blame on Purdue and Sackler family members for contributing to a public health crisis that has claimed the lives of about 500,000 people since 1999…

Overall, the company resolved U.S. Justice Department criminal and civil investigations that carried penalties and other claims exceeding $8 billion. Much of that money, though, went unpaid due to factors in Purdue's bankruptcy case.

Linha do tempo

Privacy information

Este site usa cookies e outras tecnologias de armazenamento na web. Você pode definir suas opções de privacidade abaixo. As alterações entrarão em vigor imediatamente.

Para obter mais informações sobre nosso uso de armazenamento na web, consulte nossa Política de Uso de Dados e de Cookies

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Cookies analíticos

ON
OFF

Quando você acessa nosso site, usamos o Google Analytics para coletar informações sobre sua visita. A aceitação deste cookie nos permitirá entender mais detalhes sobre sua viagem, e melhorar a forma como nós colocamos as informações na superfície. Todas as informações analíticas são anônimas e não as utilizamos para identificá-lo. O Google fornece uma opção de não inclusão no Google Analytics para todos os navegadores populares.

Cookies promocionais

ON
OFF

Compartilhamos notícias e atualizações sobre empresas e direitos humanos através de plataformas de terceiros, incluindo mídias sociais e mecanismos de busca. Estes cookies nos ajudam a entender o desempenho destas promoções.

Suas escolhas de privacidade para este site

Este site usa cookies e outras tecnologias de armazenamento da web para aprimorar sua experiência além da funcionalidade básica necessária.